Mobile Water Purification Systems offer 24/7 real-time monitoring.
Press Release Summary:
Touchscreen-operated AFS® 40E/80E/120E/150E provide clinical laboratories with reliable water purification solution for daily water volumes up to 3,000 L. Elix® electrodeionization (EDI) and ERA™ (Evolutive Reject Adjustment) technologies enable production of water meeting Clinical and Laboratory Standards Institute® (CLSI®) Clinical Laboratory Reagent Water standards. Also included, real-time monitoring and remote control help maximize water purification system and analyzer uptime.
Original Press Release:
EMD Millipore Introduces New High-Performance Water Purification Systems with 24/7 Real-Time Monitoring and Remote Control
- New AFS® 40E / 80E / 120E and 150E systems fulfill pure water needs for one or several high-throughput clinical analyzers
- Unique Elix® electrodeionization and innovative E.R.A(TM) technologies ensure constant water quality with low and predictable running costs
- Remote connection capabilities allow an unprecedented level of service in order to maximize analyzer uptime
DARMSTADT, Germany -- EMD Millipore, the Life Science business of Merck KGaA, Darmstadt, Germany, today announced the introduction of its AFS(®) 40E / 80E / 120E and 150E water purification systems. These new systems have been developed to provide clinical laboratories with an economical and reliable water purification solution for daily water volumes of up to 3000 L.
The AFS(®) 40E / 80E / 120E and 150E systems rely on two powerful technologies to produce water quality meeting Clinical and Laboratory Standards Institute(®) (CLSI(®)) Clinical Laboratory Reagent Water standards. State-of-the-art, proven Elix(®) electrodeionization (EDI) technology ensures constant water quality with low and predictable running costs, while unique E.R.A.(TM) (Evolutive Reject Adjustment) technology takes feed water quality into account in order to automatically optimize water recovery -- and reduce water usage costs.
"Biomedical laboratory managers are under constant pressure to avoid clinical analyzer downtime," notes John Sweeney, Head of Lab Solutions Business, EMD Millipore. "Water is the most frequently used fluidic reagent in clinical analyzers, and for labs handling thousands of samples a day, the choice of a water purification system is key to providing high-quality pure water and smooth operations," he explains. "Our new AFS(®) 40E / 80E / 120E and 150E systems incorporate the latest technologies, for robust and reliable performance. Our goal is to help make the biomedical lab more productive -- and these AFS(®) E systems do exactly that."
The AFS(®) 40E / 80E / 120E and 150E systems also offer users powerful 24/7 real-time monitoring and remote control over their water purification systems, as well as a new generation of enhanced services. These advanced monitoring features, along with an unprecedented level of service, also help maximize water purification system and analyzer uptime.
The systems have been designed to provide quick and precise remote diagnostics and offer proactive service in order to avoid downtime. Service starts with feed water analysis by a certified EMD Millipore Field Service Engineer prior to system installation. Then, over time, users can ensure the best upkeep of their AFS(®) E water purification system with a customized Watercare Pact service plan.
With its large new touch screen, the system is designed for intuitive operation and for supporting the user with easy step-by-step instructions during routine maintenance. Interacting with the water purification system has never been easier. For increased flexibility, the system interface can also be accessed from another location, using a PC, tablet, or smart phone through a web browser.
Mobile and customizable, the new range of systems is designed to make the best use of lab space. The quiet, compact systems are mounted on wheels, and can be moved around the lab -- or to another location -- depending on current lab requirements.
AFS(®) E system users can choose from a number of options and accessories to match their specific requirements, including an online Total Organic Carbon (TOC) monitor, degassing option, and sanitary sampling valve, among others.
Additional Resources
> Download high resolution photo
> For more information, please visit http://www.emdmillipore.com/AFSE-large
About EMD Millipore
EMD Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers' success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, EMD Millipore serves as a strategic partner to customers and helps advance the promise of life science. Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 66 countries and 2013 revenues of EUR2.6 billion. EMD Millipore is known as Merck Millipore outside of the U.S. and Canada.
For more information, please visit www.emdmillipore.com.
Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany
About Merck KGaA, Darmstadt, Germany
Merck KGaA of Darmstadt, Germany, is a leading company for innovative and top-quality high-tech products in the pharmaceutical and chemical sectors. Its subsidiaries in Canada and the United States operate under the umbrella brand EMD. Around 39,000 employees work in 66 countries to improve the quality of life for patients, to further the success of customers and to help meet global challenges. The company generated total revenues of EUR 11.1 billion in 2013 with its four divisions: Biopharmaceuticals, Consumer Health, Performance Materials and Life Science Tools. Merck KGaA of Darmstadt, Germany is the world's oldest pharmaceutical and chemical company - since 1668, the name has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent interest, the founding family remains the majority owner of the company to this day.
CONTACT: Jill DeCoste, Phone: +1 978 715 4670, Email: jill.decoste@emdmillipore.com
